Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: July 2013

Chapter 28 - Cancer

from Section 4 - The pregnant patient with coexisting disease

Summary

This chapter deals with issues related to mechanical ventilation in general and considers those relevant to the obstetric patient in particular. The most common modes of mechanical ventilation are: volume-controlled continuous mandatory ventilation (VC-CMV), pressure-controlled continuous mandatory ventilation (PC-CMV), intermittent mandatory ventilation (IMV), continuous mandatory ventilation (CMV), airway pressure release ventilation (APRV) and positive end-expiratory pressure (PEEP). All patients receiving mechanical ventilation should be monitored by pulse oximetry. Non-invasive ventilation can be delivered nasally or by face mask, using either a conventional mechanical ventilator or a machine designed specifically for this purpose. The 2009 H1N1 influenza pandemic and the particular susceptibility of pregnancy in such circumstances reinforce the need to appraise the rationale for mechanical ventilation in such patients. Finally, APRV as a ventilatory paradigm, in particular, may be particularly useful in the pregnant patient with pneumonits, acute lung injury, or acute respiratory distress syndrome (ARDS).

References

1. Van CalsterenK, HeynsL, De SmetF, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 2010;28:683–689.
2. StensheimH, MollerB, van DijkT, FossaSD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009;27:45–51.
3. International Atomic Energy Agency. Pregnancy and Radiation Protection of Patients: Pregnant Women. Vienna: International Atomic Energy Agency, 2009 (http://rpop.iaea.org/RPOP/RPoP/Content/SpecialGroups/1_PregnantWomen/index.htm, accessed 7 December 2012).
4. RajaramanP, SimpsonJ, NetaG, et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case–control study. BMJ 2011;342:d472.
5. KizerNT, PowellMA. Surgery in the pregnant patient. Clin Obstet Gynecol 2011;54:633–641.
6. KheraSY, KilukJV, HassonDM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008;14:250–254.
7. AmantF, DeckersS, Van CalsterenK, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2010;46:3158–3168.
8. KalHB, StruikmansH. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005;6:328–333.
9. SymeMR, PaxtonJW, KeelanJA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487–514.
10. Van CalsterenK, VerbesseltR, DevliegerR, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer 2010;20:1456–1464.
11. Van CalsterenK, VerbesseltR, BeijnenJ, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 2010;119:594–600.
12. Van CalsterenK, VerbesseltR, Van BreeR, et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci 2011;18:57–63.
13. CardonickE, IacobucciA. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283–291.
14. De SantisM, Di GianantonioE, StrafaceG, et al. Ionizing radiations in pregnancy and teratogenesis: a review of literature. Reprod Toxicol 2005;20:323–329.
15. EbertU, LofflerH, KirchW. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207–220.
16. CardonickE, UsmaniA, GhaffarS. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 2010;33:221–228.
17. AvilesA, NeriN. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001;2:173–177.
18. HahnKM, JohnsonPH, GordonN, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219–1226.
19. AmantF, VanCK, HalaskaMJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 2012;13:256–264.
20. Meyer-WittkopfM, BarthH, EmonsG, SchmidtS. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001;18:62–6.
21. AvilesA, NeriN, NamboMJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006;17:286–288.
22. ZemlickisD, LishnerM, ErlichR, KorenG. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 1993;13:139–143.
23. MazonakisM, DamilakisJ, TheoharopoulosN, VarverisH, GourtsoyiannisN. Brain radiotherapy during pregnancy: an analysis of conceptus dose using anthropomorphic phantoms. Br J Radiol 1999;72:274–278.
24. MazonakisM, VarverisH, FasoulakiM, DamilakisJ. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol 2003;66:333–339.
25. MazonakisM, VarverisH, DamilakisJ, TheoharopoulosN, GourtsoyiannisN. Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 2003;55:386–391.
26. LuisSA, ChristieDR, KaminskiA, KennyL, PeresMH. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol 2009;53:559–568.
27. RobinsonAA, WatsonWJ, LeslieKK. Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. Lancet Oncol 2007;8:738–743.
28. AzimHA Jr., AzimH, PeccatoriFA. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev Clin Immunol 2010;6:821–826.
29. IsaacsRJ, HunterW, ClarkK. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy: case report and literature review. Gynecol Oncol 2001;80:405–408.
30. DeckerM, RothermundtC, HollanderG, TichelliA, RochlitzC. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006;7:693–694.
31. PyeSM, CortesJ, AultP, et al. The effects of imatinib on pregnancy outcome. Blood 2008;111:5505–5508.
32. ShapiraT, PeregD, LishnerM. How I treat acute and chronic leukemia in pregnancy. Blood Rev 2008;22:247–259.
33. ConchonM, SanabaniSS, SerpaM, et al. Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy. Adv Hematol 2010;2010:136–152.
34. RizackT, MegaA, LegareR, CastilloJ. Management of hematological malignancies during pregnancy. Am J Hematol 2009;84:830–841.
35. DaleDC, CottleTE, FierCJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003;72:82–93.
36. WapnerRJ, SorokinY, MeleL, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1190–1198.
37. PavlidisN, PentheroudakisG. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res 2008;178:183–194.
38. JackischC, LouwenF, SchwenkhagenA, et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 2003;268:69–77.
39. AlexanderA, SamlowskiWE, GrossmanD, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 2003;21:2179–2186.
40. MillerK, ZawislakA, GannonC, MillarD, LoughreyM. Maternal gastric adenocarcinoma with placental metastases: what is the fetal risk?Pediatr Dev Pathol 2012;15:237–239.
41. CardonickE, DoughertyR, GranaG, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010;16:76–82.
42. ZemlickisD, LishnerM, DegendorferP, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992;166:781–787.
43. PavlidisN, PentheroudakisG. The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev 2005;31:439–447.
44. SankilaR, HeinavaaraS, HakulinenT. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect.” Am J Obstet Gynecol 1994;170:818–823.